Ross Stores, Inc. vs TransMedics Group Inc — how do they compare? Ross Stores, Inc. trades at $233.99 (market cap $75.63B), while TransMedics Group Inc trades at $74.3 (market cap $2.54B). The key difference: Ross Stores, Inc. is far larger — about 29.8× TransMedics Group Inc's market cap, and Ross Stores, Inc. pays a 0.75% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals.
| ROST | TMDX | |
|---|---|---|
Market Cap | $75.63B | $2.54B |
Sector | Consumer Cyclical | Technology |
52-Week High | $240.13 | $150.42 |
52-Week Low | $134.02 | $61.99 |
Enterprise Value | $76.23B | $2.94B |
Dividend Yield | 0.75% | — |
Signals from Pluang's Aura AI — not financial advice
Ross Stores (ROST) trades at $235.78, up 1.05% today, with a bullish technical outlook supported by moving averages and recent earnings beats. The company reported strong Q1 2026 results with 21% sales growth and expanding margins, while expanding its store footprint with 47 new locations in mid-2026. Valuation metrics show a P/E of 32.93 and robust profitability with a 38.98% ROE, though the stock trades near analyst price targets.
The outlook remains positive due to consistent earnings outperformance and store expansion, but risks include high valuation multiples and competitive retail pressures. Analyst consensus is bullish with a $259 price target, suggesting moderate upside potential from current levels amid broader market volatility.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Ross Stores is a leading American off-price apparel and home fashion retailer, operating over 1,920 stores (at the end of fiscal 2021) across the Ross Dress for Less and dd's Discounts banners. Ross offers a variety of name-brand products and targets undercutting conventional retailers' regular prices by 20%-70%. The company uses an opportunistic, flexible merchandising approach
Read more on ROST →TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →